{"id":"W2767736224","doi":"10.1002/acr.23462","title":"Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions","year":2017,"lang":"en","type":"review","venue":"Arthritis Care & Research","topic":"Osteomyelitis and Bone Disorders Research","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster Children's Hospital; University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; National Institute of General Medical Sciences; Technische Universiteit Delft; Novartis Foundation; Arthritis Foundation","keywords":"Chronic recurrent multifocal osteomyelitis; Medicine; Refractory (planetary science); Sulfasalazine; Nonsteroidal; Methotrexate; Certolizumab pegol; Osteomyelitis; Intensive care medicine; Internal medicine; Infliximab; Surgery; Physical therapy; Tumor necrosis factor alpha; Osteitis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006579006,0.0008143606,0.002806986,0.0009582792,0.001249958,0.0004021369,0.0004464047,0.0006019212,0.0001880972],"category_scores_gemma":[0.0003623151,0.000574906,0.0005351243,0.0003113302,0.001020337,0.0001337305,0.0003897047,0.001154485,0.0001554953],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00130676,"about_ca_system_score_gemma":0.008326275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007561789,"about_ca_topic_score_gemma":0.006481923,"domain_scores_codex":[0.9941056,0.0005473953,0.0008027421,0.001504064,0.001297625,0.001742624],"domain_scores_gemma":[0.9953012,0.0007978844,0.0002354218,0.001440834,0.001199832,0.001024795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003283744,0.00009372752,0.00001359132,0.01022824,0.0003380548,0.001747261,0.001261219,2.875412e-8,0.00002714724,0.00002170657,0.0005048071,0.9824805],"study_design_scores_gemma":[0.007146607,0.02045698,0.0001555651,0.04037522,0.0002679033,0.0009753602,0.002576127,6.198258e-7,0.00004530818,0.00000244546,0.9274181,0.0005797293],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01140449,0.9712675,0.000002180092,0.0005968051,0.0002491593,0.0103338,0.004093602,0.00006618868,0.001986228],"genre_scores_gemma":[0.0046605,0.9855285,0.0002031972,0.00001529059,0.002134251,0.003249103,0.001021811,0.0002168482,0.002970528],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9819008,"threshold_uncertainty_score":0.9996703,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1687250146397138,"score_gpt":0.4692906468887389,"score_spread":0.3005656322490251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}